Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Shock Wave Therapy Useful For Stress Fractures

By HospiMedica staff writers
Posted on 31 Jul 2007
Extracorporeal shock wave therapy (ESWT) is an effective way to treat resistant stress fractures in athletes, according to a new study.

Researchers from the Zensyukai Hospital Gunma Sports Medicine Research Center (Gunma, Japan) treated a total of 62 patients with ESWT between 1997 and 2003, including five athletes with chronic stress fractures that failed to heal after medical or surgical therapy. More...
The athletes were between 13 and 22 years of age and fractures were located in the leg, pubic bone, ankle, or foot. The patients were participants in baseball, basketball, marathon, or soccer. Each patient underwent one session of ESWT, performed under spinal anesthesia in an operating room.

The researchers reported the results of the treatment in five cases, and found that successful bone union was achieved in all cases roughly 3 months after ESWT and the subjects were then able to return to their sports after 3 to 6 months. The study was published in the July 2007 edition of the American Journal of Sports Medicine.

"We require additional basic and clinical studies to understand the effectiveness of ESWT, along with studies to determine the optimal energy level and impulse rate for the device,” concluded lead author Masanori Taki, M.D., and colleagues. "Nevertheless, when appropriately used, ESWT can be a safe and effective treatment for stress fractures, especially in resistant cases.”

ESWT is a noninvasive surgical procedure that uses sound waves to stimulate healing in some physical disorders. Because there is no incision, ESWT offers two main advantages over traditional surgical methods: Fewer potential complications and a faster return to normal activity. ESWT has been used extensively for several years to treat plantar fasciitis and other disorders.


Related Links:
Zensyukai Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.